Making Value-Based Contracting Stick

DIA members: Sign in below to see content options. Not a member? Enjoy this preview, then see below to join DIA today!

Read Full Transcript     Watch Interactive Transcript     Listen and Download

Key Takeaways

Outcomes-based contracts offer different benefits for different stakeholders:

  • For biopharmaceutical companies, VBP arrangements can expand market access and improve a drug’s formulary position.
  • For payers, these agreements can lower costs and increase performance.
  • For providers, these arrangement reduce risk.
  • For patients, VBP agreements lead to less out-of-pocket expenses.

Increasing healthcare costs — the average US health system spends more than 55 percent of its total drug spend on only 3 percent of drug volume — have accelerated the need for outcomes research and are leading to increase utilization of value-based purchasing agreements.

Patient and clinician relevant, standardized outcomes will be the key metric in moving toward value-based care.

Member Benefits

  • Full Video, Transcript and Audio-only Version Available

See All Insider Access Videos

This content is for DIA Members only. JOIN NOW for full access!